Market Newsdesk

The family-owned grocer is now partnering with Instacart to offer delivery in as fast as an hour across Greater St. Louis and the Lake of the Ozarks, while streamlining order fulfillment through a new electronic shelf label integration

SAN FRANCISCO and ST. LOUIS, April 8, 2025 /PRNewswire/ — Instacart (NASDAQ: CART), the leading grocery technology company in North America, and Dierbergs Markets, a 27-store independent grocer headquartered near St. Louis, Missouri today announced a new partnership to offer same-day delivery in as fast as an hour. The partnership will add Dierbergs to the Instacart App, enabling customers to access fresh groceries and household goods for same-day delivery. Dierbergs is also deploying Carrot Tags, Instacart’s electronic shelf label (ESLs) software integration, to help Instacart Shoppers easily locate ordered items and improve order accuracy.

“We couldn’t be more thrilled to welcome Dierbergs Markets to the Instacart platform, bringing their customers the ease of same-day delivery in as fast as one hour,” said Nick Nickitas, General Manager of Local Independent Grocery at Instacart. “Our new partnership with Dierbergs is an exciting milestone, underscoring how Instacart’s solutions can amplify an independent grocer’s digital and in-store experience. With Dierbergs now live on the Instacart App and leveraging Carrot Tags in stores, their customers will enjoy faster, more accurate orders, and seamless shopping like never before.”

“As a family-run business for more than 170 years, we’re proud to continue evolving with our customers’ needs and preferences,” said Laura Dierberg Padousis, Executive Vice President of Dierbergs Markets. “Instacart has been an exceptional partner as we team up to make life a little easier for our customers. We’re excited to bring the fresh, quality foods and household essentials our customers love right to their doorstep with same day delivery.”

To celebrate the partnership, Dierbergs and Instacart are offering $15 off of orders $50 or more to all customers making a purchase at Dierbergs via the Instacart App. No code necessary while supplies last.

Carrot Tags’ pick to light functionality seamlessly integrates to Dierbergs’ electronic shelf labels, allowing Instacart Shoppers to activate items from their picking list within the Instacart Shopper App. In turn, this provides easier and more accurate order fulfillment to Instacart Shoppers while also improving e-commerce efficiency and found rates to boost customer satisfaction by ensuring customers receive exactly what they ordered. 

To begin shopping from Dierbergs Markets for same-day delivery via Instacart, customers can visit instacart.com/store/dierbergs-markets/storefront or select the Dierbergs Markets storefront on the Instacart App. 

Dierbergs Markets joins more than 1,800 retail banners already available on the Instacart App – ranging from grocery to beauty to home improvement to pet supplies. Carrot Tags is part of Instacart’s Connected Stores suite of technologies, designed to bridge the online and in-store shopping experience for both retailers and customers.

About Instacart

Instacart, the leading grocery technology company in North America, works with grocers and retailers to transform how people shop. The company partners with more than 1,800 national, regional, and local retail banners to facilitate online shopping, delivery and pickup services from more than 100,000 stores across North America on the Instacart Marketplace. Instacart makes it possible for millions of people to get the groceries they need from the retailers they love, and for approximately 600,000 Instacart shoppers to earn by picking, packing and delivering orders on their own flexible schedule. The Instacart Platform offers retailers a suite of enterprise-grade technology products and services to power their e-commerce experiences, fulfill orders, digitize brick-and-mortar stores, provide advertising services, and glean insights. With Instacart Ads, thousands of CPG brands – from category leaders to emerging brands – partner with the company to connect directly with consumers online, right at the point of purchase. With Instacart Health, the company is providing tools to increase nutrition security, make healthy choices easier for consumers, and expand the role that food can play in improving health outcomes. For more information, visit www.instacart.com/company, and to start shopping, visit www.instacart.com. Maplebear Inc. is the registered corporate name of Instacart.

About Dierbergs Markets
Dierbergs Markets is a privately owned, family-run business in its 4th generation of leadership. Originating in 1854 with its first location on Olive Street Road, it has grown to 27 stores primarily in the St. Louis region, with two stores in Illinois, and one in the OzarksDierbergs currently has more than 3,400 Associates company-wide who share in our 170-year history and uphold our reputation built on hard work, personal service and a commitment to meeting the growing needs of our area through community service. Follow Dierbergs on social @dierbergs.

*$15 off is valid through 06/30/2025 at 11:59PM ET and is valid only in the United States for three orders of $50 or more with Dierbergs Markets and purchased through Instacart.com, while supplies last. Discount will be applied to the total purchase price for all non-alcohol products, and excludes taxes, service fees, special handling fees and/or other fees; offer cannot be applied to alcohol products. Deliveries subject to availability. In order to take advantage of this offer, customers must have a valid account on Instacart.com with a valid form of accepted payment on file. Only three offers per household. Instacart reserves the right to modify or cancel this offer at any time. Offer may not be sold, copied, modified, transferred or used retroactively for prior purchases. Void where restricted or prohibited by law. Offer may not be combined with any other sale, promotion, discount, code, coupon, and/or offer. Offer has no cash value. Instacart is not a retailer or seller. Instacart may not be available in all zip or post codes.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/instacart-and-dierbergs-markets-partner-to-launch-same-day-delivery-and-carrot-tags-302422832.html

SOURCE Maplebear Inc. dba Instacart

Del-desiran first-ever investigational treatment for DM1 to receive Orphan Drug designation in Japan 

SAN DIEGO
, April 8, 2025 /PRNewswire/ — Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced that the Japan Ministry of Health, Labour and Welfare (MHLW) has granted Orphan Drug designation (ODD) to delpacibart etedesiran (del-desiran) for the treatment of myotonic dystrophy type 1 (DM1), an investigational treatment designed to address the root cause of DM1, an underrecognized, progressive and often fatal neuromuscular disease with no approved therapies. Del-desiran is the first investigational treatment for DM1 to receive Orphan Drug designation in Japan. Del-desiran has also received Breakthrough Therapy, Orphan Drug and Fast Track designations by the U.S. Food and Drug Administration (FDA) and Orphan designation by the European Medicines Agency (EMA).

“This decision by MHLW further reinforces the significant potential of del-desiran to address the root cause of DM1 and the urgent need to bring an approved therapy to the many people impacted by this devastating rare disease in Japan and around the world,” said Steve Hughes, M.D., chief medical officer at Avidity. “We are very encouraged by del-desiran data reported from the MARINA and MARINA-OLE studies thus far, demonstrating favorable long-term safety and tolerability, reversal of disease progression, and consistent and durable improvements in multiple clinical endpoints. Looking ahead, there are multiple key milestones this year as we complete enrollment in the phase 3 HARBOR trial and continue to advance our global commercialization preparations to potentially deliver the first globally approved drug for people living with DM1.”

Avidity has aligned with global regulators on the registrational path for del-desiran for the treatment of DM1, which informed the design of the ongoing Phase 3 HARBOR™ study. Avidity expects to complete participant enrollment in the Phase 3 HARBOR study in mid-2025 and submit marketing applications starting 2026 in the U.S., European Union and Japan.

Japan’s MHLW grants Orphan Drug designation to drugs in development for the treatment of diseases that affect fewer than 50,000 patients in Japan and for which there is a high unmet medical need. An investigational therapy is eligible to qualify for Orphan Drug designation if there is no approved alternative treatment option or if there is high efficacy or safety expected compared to existing treatment options. Orphan Drug designation provides certain benefits, including prioritized consultation regarding clinical development, reduced consultation fees, tax incentives, priority review of applications, reduced application fees, and extended registration validity period.

About the Phase 3 HARBOR™ Trial
The global Phase 3 HARBOR™ trial is a randomized, placebo-controlled, double blind pivotal study designed to evaluate del-desiran in approximately 150 people (age 16 and older) living with DM1. The trial will be conducted at approximately 40 sites globally. Patients will be administered either del-desiran or placebo (1:1) every eight weeks. HARBOR is designed to assess multiple key functional aspects of DM1. The primary endpoint is video hand opening time (vHOT), a measurement of myotonia, which is a hallmark symptom of DM1. Key secondary endpoints include muscle strength as measured by hand grip strength and quantitative muscle testing (QMT) total score, and activities of daily living as measured by DM1-Activ. All study participants, regardless of whether they receive active treatment or placebo, will have the option to enroll into an open-label extension trial. For more information about the HARBOR trial, visit the HARBOR study website or visit http://www.clinicaltrials.gov and search for NCT06411288.

About the Phase 2 MARINA-OLE™ Study
MARINA-OLE™ is an open-label, multi-center trial designed to evaluate the long-term safety and tolerability of del-desiran in participants with DM1 who were previously enrolled in the MARINA^® Phase 1/2 trial. This trial will continue to evaluate the safety, tolerability, PK, PD, and efficacy of del-desiran in participants enrolled in the randomized, placebo-controlled, Phase 1/2 MARINA clinical trial. Participants enrolled in the MARINA-OLE study receive quarterly doses of del-desiran regardless of whether they received active treatment or placebo in the MARINA study. The total duration of active treatment with del-desiran in the MARINA-OLE study is approximately 24 months. Once patients have completed active treatment, there will be a nine-month safety follow-up period. Avidity may extend active treatment beyond 24 months at a future timepoint. For more information on this study click here or visit http://www.clinicaltrials.gov and search for NCT05479981.

About Del-desiran
Del-desiran, Avidity’s lead product candidate utilizing its AOC platform, is designed to address the root cause of DM1 by reducing levels of a disease-related mRNA called DMPK. Del-desiran consists of a proprietary monoclonal antibody that binds to the transferrin receptor 1 (TfR1) conjugated with a siRNA targeting DMPK mRNA. Del-desiran is currently being assessed in the global Phase 3 HARBOR™ trial and in the ongoing MARINA-OLE™ trial in people with DM1. Long-term data from the MARINA-OLE trial showed reversal of disease progression in people living with DM1 across multiple endpoints including video hand opening time (vHOT) as a measure of hand function and myotonia, muscle strength and activities of daily living when compared to END-DM1 natural history data. Del-desiran has received Breakthrough Therapy, Orphan Drug and Fast Track designations by the U.S. Food and Drug Administration (FDA) and Orphan designation by the European Medicines Agency (EMA).

About Myotonic Dystrophy Type 1
Myotonic dystrophy type 1 (DM1) is an underrecognized, autosomal dominantly inherited, progressive and often fatal disease caused by a triplet-repeat in the DMPK gene, resulting in a toxic gain of function mRNA. The disease is highly variable with respect to severity, presentation and age of onset, however all forms of DM1 are associated with high levels of disease burden and may cause premature mortality. DM1 primarily affects skeletal and cardiac muscle, however patients can suffer from a constellation of manifestations including myotonia and muscle weakness, respiratory problems, fatigue, hypersomnia, cardiac abnormalities, severe gastrointestinal complications, and cognitive and behavioral impairment. Currently, there are no approved treatments for people living with DM1.

About Avidity 
Avidity Biosciences, Inc.’s mission is to profoundly improve people’s lives by delivering a new class of RNA therapeutics – Antibody Oligonucleotide Conjugates (AOCs™). Avidity is revolutionizing the field of RNA with its proprietary AOCs, which are designed to combine the specificity of monoclonal antibodies with the precision of oligonucleotide therapies to address targets and diseases previously unreachable with existing RNA therapies. Utilizing its proprietary AOC platform, Avidity demonstrated the first-ever successful targeted delivery of RNA into muscle and is leading the field with clinical development programs for three rare neuromuscular diseases: myotonic dystrophy type 1 (DM1), Duchenne muscular dystrophy (DMD) and facioscapulohumeral muscular dystrophy (FSHD). Avidity is also advancing two wholly-owned precision cardiology development candidates addressing rare genetic cardiomyopathies. In addition, Avidity is broadening the reach of AOCs with its advancing and expanding pipeline including programs in cardiology and immunology through key partnerships. Avidity is headquartered in San Diego, CA. For more information about our AOC platform, clinical development pipeline and people, please visit www.aviditybiosciences.com and engage with us on LinkedIn and X.

Forward-Looking Statements
Avidity cautions readers that statements contained in this press release regarding matters that are not historical facts are forward-looking statements. These statements are based on the company’s current beliefs and expectations. Such forward-looking statements include, but are not limited to, statements regarding: planned marketing applications for del-desiran in the U.S., European Union and Japan, and the timing thereof; Avidity’s plans to become a global commercial organization and the status of its commercialization efforts; the characterization of data associated with del-desiran in the MARINA and MARINA-OLE studies, the conclusions drawn therefrom, and the impact of such data on the advancement of del-desiran and its ability to treat DM1; the designs, goals, statuses and enrollment levels of, and plans for, the MARINA-OLE and HARBOR studies; Avidity’s platform, planned operations and programs; and Avidity’s cash position and runway.

The inclusion of forward-looking statements should not be regarded as a representation by Avidity that any of these plans will be achieved. Actual results may differ from those set forth in this press release due to the risks and uncertainties inherent in Avidity’s business and beyond its control, including, without limitation: Avidity may not realize any benefit from Orphan Drug designation of del-desiran by global health authorities; the data and results produced in Avidity’s ongoing studies of del-desiran as of the most recent respective cutoff dates may not be indicative of final results, may not support a BLA submission, may not be satisfactory to the MHLW and other regulators, and new analyses of existing data and results may produce different conclusions than established as of the date hereof; even if approved, Avidity may not be able to execute any successful product launches; Avidity’s efforts to build a global commercial organization may be unsuccessful; unexpected adverse side effects to, or inadequate efficacy of, del-desiran that may delay or limit its development, regulatory approval and/or commercialization; later developments with the MHLW and other global regulators that could be inconsistent with the feedback received to date; Avidity’s approach to the discovery and development of product candidates based on its AOC™ platform is unproven and may not produce any products of commercial value; potential delays in the commencement, enrollment, data readouts and completion of the MARINA-OLE and HARBOR studies; Avidity’s dependence on third parties in connection with preclinical and clinical testing and product manufacturing; legislative, judicial and regulatory developments in the United States and foreign countries; Avidity could exhaust its available capital resources sooner than it currently expects; and other risks described in Avidity’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024. Avidity cautions readers not to place undue reliance on these forward-looking statements, which speak only as of the date hereof, and the company undertakes no obligation to update such statements to reflect events that occur or circumstances that arise after the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement, which is made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.

Investor Contact:

Kat Lange
(619) 837-5014
[email protected]

Media Contact:
(619) 837-5016
[email protected]

View original content to download multimedia:https://www.prnewswire.com/news-releases/avidity-biosciences-receives-orphan-drug-designation-in-japan-for-delpacibart-etedesiran-del-desiran-for-treatment-of-myotonic-dystrophy-type-1-302422550.html

SOURCE Avidity Biosciences, Inc.

FREMONT, Calif.
, April 8, 2025 /PRNewswire/ — Socket Mobile, Inc. (NASDAQ: SCKT), a leading provider of data capture solutions, today announced its entry into the $27 billion mobile handheld computing market with the launch of the XtremeScan™ iXG and iXS Series, powered by iOS 18.3. The market is projected to grow to $40 billion by 2034, driven by rising demand for mobile solutions in industrial environments.

In response to growing demand, Socket Mobile’s new iXG and iXS Series represent a breakthrough in the integration of iOS-powered devices into industrial settings. The iOS operating system offers unparalleled ease of use, robust security features, and a vast ecosystem of applications, making it an ideal platform for Socket Mobile’s handheld computing solutions.

“With the XtremeScan iXG and iXS Series, we’re combining our most rugged, high-performance scanning technology with one of the world’s most widely used mobile devices and operating systems: Apple’s iPhone and iOS,” said Dave Holmes, Chief Business Officer at Socket Mobile. “This launch empowers industrial customers to deploy fully integrated mobile handheld computers that are intuitive, powerful, and purpose-built for harsh environments. The iXG and iXS Series establish a clear handheld computing choice for industrial users, and we expect these products to drive a positive impact on our revenue by Q4.”

The iXG and iXS Series come with a fully integrated, factory-new iPhone 16e. Its powerful performance and user-friendly interface, combined with the XtremeScan’s ruggedized design and advanced data capture capabilities, make the new products a perfect fit for industrial users.

With mobile operations accelerating across industries, the XtremeScan iXG and iXS Series represent a pivotal evolution of Socket Mobile’s hardware and software portfolio. These devices are designed to serve as full-featured handheld computers, integrating high-performance long-range barcode scanning with the connectivity, app compatibility, and user-friendly interface of the iOS platform. Together, these capabilities empower workers to capture data more accurately, act more decisively, and perform critical tasks with greater speed and confidence.

The new series launches with two models: the compact, handheld iXS963 and the iXG963, which features an ergonomic pistol grip. Both are housed in Socket Mobile’s ultra-rugged XtremeScan enclosure, designed to protect the iPhone 16e while withstanding the physical demands of industrial use. They also feature Socket Mobile’s longest-range scanning engine to date, capable of reading 1D/2D barcodes at distances up to 46 feet—supporting workflows that require extended reach for high or hard-to-access labels. This combination of military-grade durability and performance unlocks new possibilities for iPhone-based computing in even the harshest environments.

The iXG963 and iXS963 are fully compatible with all existing applications that use the latest version of Socket Mobile’s CaptureSDK with Bluetooth Low Energy (BLE) enabled and can be evaluated immediately without any additional work. Application developers who do not yet support Socket Mobile’s expansive range of data capture devices can do so with CaptureSDK. CaptureSDK gives app providers reliable and consistent data capture performance, enabling their apps to capture data efficiently in the physical world. By integrating CaptureSDK, app providers can maximize the value of their solution and increase their customer’s overall productivity and satisfaction. CaptureSDK-enabled apps allow end-users to interchange any of Socket Mobile’s data capture devices, giving them the freedom to choose the best reader for their needs at any given time.   

The XtremeScan Grip iXG963 and XtremeScan iXS963 are available now on the Socket Mobile website with MSRPs of $1,947.00 and $1,847.00

Apple, iPhone, and iOS are trademarks of Apple Inc., registered in the U.S. and other countries and regions.

Media Contact: David Holmes
[email protected] 

View original content to download multimedia:https://www.prnewswire.com/news-releases/socket-mobile-enters-27b-handheld-computing-market-with-ios-powered-ruggedized-devices-302422689.html

SOURCE Socket Mobile, Inc.

NEW YORK
, April 8, 2025 /PRNewswire/ — Purcell & Lefkowitz LLP announces that it is investigating Northwest Bancshares, Inc. (NASDAQ: NWBI) on behalf of the company’s shareholders.  The investigation seeks to determine whether Northwest Bancshares’s directors breached their fiduciary duties in connection with recent corporate actions.

If you are a shareholder of Northwest Bancshares, Inc. and are interested in obtaining additional information regarding your rights and options, free of charge, please visit us at: https://pjlfirm.com/northwest-bancshares-inc/

You may also contact Robert H. Lefkowitz, Esq. either via email at [email protected] or by telephone at 212-725-1000.  One of our attorneys will personally speak with you about the case at no cost or obligation.

Purcell & Lefkowitz LLP is a law firm exclusively committed to representing shareholders nationwide who are victims of securities fraud, breaches of fiduciary duty and other types of corporate misconduct. For more information about the firm and its attorneys, please visit https://pjlfirm.com.   Attorney advertising. Prior results do not guarantee a similar outcome. 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-alert-purcell–lefkowitz-llp-announces-shareholder-investigation-of-northwest-bancshares-inc-nasdaq-nwbi-302422798.html

SOURCE Purcell & Lefkowitz LLP

Zillow’s AI-powered Showcase experience delivers premium listing visibility, helping HomeServices agents attract more buyers and win more listings in a competitive market

SEATTLE
, April 8, 2025 /PRNewswire/ — Zillow^® and HomeServices of America^® are together empowering agents within HomeServices of America companies through the use of Zillow Showcase℠, an AI-powered listing experience exclusive to Zillow. This collaboration has provided significant advantages to HomeServices of America since its agents began using Zillow Showcase last fall. HomeServices of America operates leading brokerage companies nationwide. The enhanced listing experience boosts the online presence of HomeServices’ brands, attracts more buyers and drives business growth in a competitive market.

Zillow Showcase helps HomeServices agents present homes with rich, interactive listings designed to captivate potential buyers. Listings with Zillow Showcase tend to sell for 2% more than standard listings, adding more than $9,000 to the average sale price. Homes also go pending faster, typically within the first 14 days.¹

“At HomeServices of America, we believe in empowering our clients when it comes to marketing their home, and we’re excited to bring the Zillow Showcase offering to our agents,” said Chris Kelly, executive vice president of HomeServices of America. “Showcase amplifies a home’s exposure by tapping into Zillow’s consumer reach, giving our sellers greater visibility in the marketplace. It also provides our agents with a powerful differentiator to win more listings and deliver even stronger results on behalf of their clients.”

Showcase listings
 on Zillow feature a high-tech, visually rich listing design with high-resolution, scrolling hero images, room-by-room photo organization and an interactive floor plan to engage shoppers. These standout listings are easily discoverable on Zillow thanks to special search markers and tags. This additional exposure gives sellers working with HomeServices of America agents a competitive edge just as the spring housing market heats up and helps drive engagement with motivated buyers – active Showcase listings receive 81% more page views, 80% more saves, 90% more shares, compared to similar nearby non-Showcase listings on Zillow.¹

“I plan to use Zillow Showcase on every listing as one more thing that sets me apart from the competition,” said Debbie Byrnes, licensed real estate agent with Intero, a Berkshire Hathaway affiliate.

With Zillow’s high-intent shopping audience, Zillow Showcase enhances agent exposure and brand visibility, leading to tangible results. Agents using Zillow Showcase on more than half of their listings on Zillow are winning 30% more listings than similar non-Showcase agents.¹ Each Showcase listing is also featured in a dedicated email to interested shoppers, highlighting the agent’s name and brokerage branding.

“We are thrilled to support HomeServices of America in delivering exceptional service and results to their clients with Zillow Showcase, further solidifying their position as a leader in residential real estate,” said Soumya Tulloss, Zillow senior vice president of agent sales. “Zillow Showcase provides brokers with a unique market advantage, making it an invaluable tool for recruiting and retaining top agents through unparalleled marketing exposure they can’t get elsewhere.”

HomeServices of America joins the fast-growing ranks of agents and brokers who are offering Zillow Showcase to their clients. Brokerages interested in Zillow Showcase can visit zillowshowcase.com. Zillow Showcase is available nationwide.

About Zillow Group: 
Zillow Group, Inc. (Nasdaq: Z and ZG) is reimagining real estate to make home a reality for more and more people. As the most visited real estate website in the United States, Zillow and its affiliates help people find and get the home they want by connecting them with digital solutions, dedicated partners and agents, and easier buying, selling, financing, and renting experiences.

Zillow Group’s affiliates, subsidiaries and brands include Zillow^®, Zillow Premier Agent^®, Zillow Home Loans℠, Zillow Rentals^®, Trulia^®, Out East^®, StreetEasy^®, HotPads^®, ShowingTime+℠, Spruce^®, and Follow Up Boss^®.

All marks herein are owned by MFTB Holdco, Inc., a Zillow affiliate. Zillow Home Loans, LLC is an Equal Housing Lender, NMLS #10287 (www.nmlsconsumeraccess.org). © 2024 MFTB Holdco, Inc., a Zillow affiliate.

About HomeServices of America:
HomeServices of America is, through its operating companies, the country’s preeminent provider of homeownership services, including brokerage, mortgage, franchising, title, escrow, insurance, and relocation services. HomeServices of America is the owner of the Berkshire Hathaway HomeServices franchise network. HomeServices is owned by Berkshire Hathaway Energy, a consolidated subsidiary of Berkshire Hathaway Inc. HomeServices’ operating companies offer integrated real estate services, including brokerage services, mortgage originations, title and closing services, property and casualty insurance, home warranties, and other homeownership services. Information about HomeServices is available at www.homeservices.com.

(ZFIN)

¹
 For all Showcase claims, visit: https://showingtimeplus.com/showcase-facts.

View original content to download multimedia:https://www.prnewswire.com/news-releases/zillow-product-partnership-with-homeservices-of-america-empowers-agents-with-zillow-showcase-302422833.html

SOURCE Zillow

Unified ESG Planning and Reporting now supports Scope 1, 2 and 3 emissions frameworks

BIRMINGHAM, Mich.
, April 8, 2025 /PRNewswire/ — OneStream, Inc. (Nasdaq: OS), the leading enterprise Finance management platform that modernizes the Office of the CFO by unifying core finance and operational functions – including financial close, consolidation, reporting, planning and forecasting, today announced its new ESG Reporting & Planning solution. This solution enables OneStream customers to seamlessly collect, analyze, report and plan for ESG requirements – including Scope 1, 2 and 3 emissions – within OneStream’s unified platform.

“Despite the recent proposed scaling back of ESG and sustainability reporting regulations mainly aimed at small and midsize enterprises, larger enterprises covered by EU mandates will still need to meet reporting standards, albeit on a more forgiving timetable,” said Robert Kugel, Executive Director who leads the Office of Finance practice and the AI for Business efforts at ISG Software Research. “Moreover, enterprises that see value in reducing costs by consuming less energy and water while reducing GHG emissions must have systems in place that enable them to manage to ESG objectives. They will need software that allow them to reliably capture, plan, forecast and report ESG metrics and align them to financial planning and reporting.”

OneStream’s ESG Reporting & Planning solution unifies ESG data and processes in a single platform—empowering Finance leaders to link sustainability efforts to financial performance. With support for target setting, scenario modelling, and Scope 1, 2, and 3 reporting, it helps businesses meet global compliance and make data-driven decisions that guide business performance. Key features of OneStream’s ESG Reporting & Planning solution include:

• Unified ESG Data Collection, Reporting & Planning: Collect activity, using industry standards or customized factors to calculate Scope 1, 2 and 3 emissions and carbon intensity.
• Align ESG Planning & Reporting: Create, configure and align ESG metadata model requirements with the same data model used for financial reporting and planning.
• Govern ESG Planning & Reporting Processes: Create end-to-end user workflows to collect quantitative and qualitative data through dynamic interfaces to ensure completeness and timely delivery of auditable data.
• Enhance ESG Planning & Forecasting: Forecast ESG KPIs to provide transparency for the organization into your financial and ESG target achievements.
• Manage Renewable Energy Contracts: Manage Renewable Energy Contracts (RECs, PPAs) throughout the organization and align calculations to Scope 2 Market Method in a unified data model.

“Global businesses that align sustainability and carbon emissions reporting with financial performance have a stronger competitive advantage,” said Matt Rodgers, EVP, EMEA and ESG Executive Lead at OneStream. “Our recent Finance 2035: Return to Investment report found 73% of investors believe strong ESG credentials are key to global competitiveness. Today’s launch of ESG Reporting & Planning signifies our commitment to finance-led business planning – enabling Finance leaders to align sustainability with strategy so they can steer their businesses towards growth.”

For more information about OneStream’s ESG Reporting & Planning solution, visit here.

About OneStream

OneStream is how today’s Finance teams can go beyond just reporting on the past and Take Finance Further by steering the business to the future. It’s the leading enterprise finance platform that unifies financial and operational data, embeds AI for better decisions and productivity, and empowers the CFO to become a critical driver of business strategy and execution.

We deliver a comprehensive cloud-based platform to modernize the Office of the CFO. Our Digital Finance Cloud unifies core financial and broader operational data and processes and embeds AI for better planning and forecasting, with an extensible architecture, so customers can adopt and develop new solutions, achieving greater value as their business needs evolve.

With over 1,600 customers, including 17% of the Fortune 500, more than 300 go-to-market, implementation, and development partners and over 1,500 employees, our vision is to be the operating system for modern finance. To learn more, visit onestream.com.

Contacts

MEDIA CONTACT

Jaclyn Proctor

Media Relations Contact
OneStream
[email protected] 

View original content to download multimedia:https://www.prnewswire.com/news-releases/onestream-announces-new-esg-reporting–planning-solution-to-help-cfos-navigate-evolving-reporting-demands-302422502.html

SOURCE OneStream, Inc.

Microsoft survey reveals that 56% of U.S. Latina moms who use AI say it has become “the newest member of their parenting village they never knew they needed”; Abuela-Approved AI shines a light on modern-day Latina moms who embrace AI to help pass on their culture and expand their village of motherhood support

Microsoft previews new native Spanish-language voice features for Copilot to provide a more authentic user experience for Spanish speakers

REDMOND, Wash.
, April 8, 2025 /PRNewswire/ — Today, Microsoft shared the results of a new survey that shows that 56% of Latina moms who currently use AI agree that it is the “member of their parental support village that they never thought they needed.” For generations, many Latina moms have leaned on the wisdom and guidance passed down from their mothers and abuelas. But in today’s geographically dispersed, tech-forward world, AI has emerged as a new member of that village, pairing the traditional wisdom of abuelas with the efficiency of technology.

Tech meets tradition

When it comes to navigating modern-day motherhood, some Latinas overwhelmingly rely on their mothers for support, with 70% turning to them for parenting guidance, according to the survey. Yet less than 10% currently rely on AI for the same purpose. This underscores an opportunity for AI technology, like Microsoft Copilot, to complement traditional support systems, offering a sometimes more objective and readily available resource for moms.

The survey also highlights the growing role of AI in the lives of Latina moms, particularly for practical needs and creative inspiration. Approximately 60% of the Latina moms surveyed report using AI-powered technology for everyday tasks, with the most common usage for activities being entertainment (57%), personal growth (56%), work-related tasks (51%) and language translation (46%). In addition, among respondents already using AI-powered technology, a growing number, 38%, are tapping into it for parental guidance—suggesting that AI appears to be an emerging source of emotional support. In fact, about two thirds (67%) of Latina moms cite convenience (24/7 availability) as the top reason they would use AI more than advice from other people, and about half (48%) mention AI being a nonjudgmental source of support. 34% of Latina moms also cite stress management and the ability to ask sensitive questions without being judged as top benefits of using AI for parenting support.

As personalization in AI creates individual experiences, it can be a new tool for Latina moms navigating the delicate balance between tradition and modernity when raising bicultural children and passing on important cultural values and traditions. In fact, more than half of survey respondents cited family recipes (58%), culturally relevant moments (52%) and preservation of native language (43%) as areas where AI can serve as a bridge between honoring the past while embracing the future.

“As someone who was raised by a Mexican mother, in a household deeply rooted in Hispanic tradition, I understand the importance of unique family experiences that shape our lives,” said Yusuf Mehdi, executive vice president and chief consumer marketing officer at Microsoft. “Every day we hear incredible stories of how Copilot makes people’s life easier by understanding the greater context of their lives and showing up and offering support on their terms. This is one of the many reasons I believe deeply in our vision to build Copilot as your AI companion.”

Native Spanish-language voices coming soon

Copilot will soon offer users even more culturally authentic ways to embrace that support with the addition of two new native Spanish speaking voices, Elm and Alder, in Copilot Voice. Once available anyone can select Elm or Alder in their voice settings and whether they are speaking Spanish, English, or both, can experience a more familiar and natural dialogue as if they were talking to a native Spanish-speaking friend. 

Within a voice conversation, users will also be able to try Copilot Vision, which allows Copilot to see what they are seeing or browsing and talk with Copilot and get help or advice right where they need it. Copilot Vision is available in the Edge browser, Copilot for iOS and Android apps in the United States. 

With these and many other features, Microsoft empowers moms to balance their traditional values with modern resources, showcasing how technology can complement their parenting journey.

Abuela-Approved AI

Microsoft is clear that Copilot is not a replacement for traditional advice—it could be the modern-day “comadre” (a Spanish term of endearment often used to describe a close friend) helping to provide practical, creative, emotional and cultural guidance for today’s parenting.

Leading up to Mother’s Day, Microsoft is partnering with social media creators and their moms (abuelas) to showcase how AI has earned their mom’s stamp of approval. Through a concept called Abuela-Approved AI, moms will be introduced to ways AI can streamline their lives and expand their circle of support. Joined by Jeannette Reyes, internet personality, lifestyle creator, mom and podcast host, Abuela-Approved AI also features Michelle Disla, food enthusiast and recipe creator, Jennifer Lee, comedy content creator, and Damaris de la Cruz, lifestyle creator and shopping expert, who will share the ways they’re welcoming Microsoft Copilot into their family while continuing to hold on to tradition.

On April 8, Microsoft will gather these creators and others, along with their moms (abuelas), in New York City to discuss how technology helps balance motherhood and cultural roots. A fireside chat called “Copilot as your comadre” and moderated by Sarah DiDonato, head of Hispanic communications at Microsoft, will begin with Mehdi and feature Reyes and her mom Milly; Brittany Valdes, Microsoft employee and founder of The Mom Economy; and Laura Parra Rangel, product designer for Microsoft AI. The interactive discussion will bring to life how AI can bridge generations and how technology can coexist with cultural values and tradition.    

“I’m excited to partner with Microsoft and contribute to a larger conversation around parenting in the tech age, especially as a mom navigating a second act in my career,” said Reyes. “Like so many, I’m balancing marriage, motherhood and a multigenerational household, and I love sharing my experiences alongside my mom, Milly, who brings her immense wisdom with a touch of comedy that captures the special dynamic between mom and abuela. Copilot has become a welcome addition to my family, offering insightful, personalized, and real-time support that even my mom approves of.”

The creators invited to the event will amplify how the survey revealed ways that some Latina moms are turning to AI for support, including:

• Practical: Helping moms tackle challenges, from supporting children’s academic success, managing household finances and achieving personal growth goals to managing schedules, planning family events and generally staying on top of to-dos
• Creative: Providing fresh ideas for meaningful family gatherings, creative school projects, or preparing meals that honor heritage, as well as helping moms with age-appropriate activities for children at every stage
• Emotional: For the times when moms need a judgment-free perspective on sensitive parenting topics, offering culturally relevant parenting tips (from toddlers to teenagers), inspired by the wisdom of abuelas, while also addressing the challenges of modern motherhood
• Cultural: Helping preserve important cultural nuances like language, food and customs with her bicultural children

To learn more about Microsoft Copilot and the Abuela-Approved AI concept, visit aka.ms/Abuela and join the conversation online using #AbuelaApprovedAI to share how Microsoft Copilot has become your modern-day “comadre.”

Microsoft Copilot is available for free via mobile app for iOS and Android, on Microsoft Copilot + PCs, for Mac and on web.

About Microsoft
Microsoft (Nasdaq “MSFT” @microsoft) creates platforms and tools powered by AI to deliver innovative solutions that meet the evolving needs of our customers. The technology company is committed to making AI available broadly and doing so responsibly, with a mission to empower every person and every organization on the planet to achieve more.

Contact:
Shantal Gonzalez
[email protected] 

View original content to download multimedia:https://www.prnewswire.com/news-releases/microsoft-survey-among-latina-mothers-explores-the-intersection-of-ai-technology-and-modern-day-motherhood-302423354.html

SOURCE Microsoft Corp.

• Q1 2025 U.S. common dividend increases were $19.5 billion, up 37.0% from $14.2 billion in Q4 2024 and down 14.1% from $22.7 billion in Q1 2024.
• Q1 2025 U.S. common dividend decreases were $4.2 billion, up 68.0% from $2.5 billion in Q4 2024, and down 37.7% from $6.7 billion in Q1 2024.
• Q1 2025 net indicated dividend rate change increased $15.3 billion. 
• For the 12-months ending March 2025, U.S. common dividend increases were $68.2 billion up 0.2% from the 12-month March 2024 period’s $68.1 billion; decreases were down 38.3% to $15.6 billion compared to $25.2 billion for the prior 12-month period.
• The net 12-month March 2025 indicated dividend increase was $52.7 billion compared to $42.8 billion for the prior 12-month March 2024 period. 

NEW YORK
, April 8, 2025 /PRNewswire/ — S&P Dow Jones Indices today announced the indicated dividend net changes (increases less decreases) for U.S. domestic common stocks increased $15.3 billionduring Q1 2025, compared to the $11.7 billion increase in Q4 2024 and the $16.0 billion increase in Q1 2024. Increases were $19.5 billion versus $14.2 billion for Q4 2024 and $22.7 billion in Q1 2024. Decreases were $4.2 billion compared to $2.5 billion in Q4 2024 and $6.7 billion in Q1 2024. 

For the 12-months ending March 2025, the net dividend rate increased $52.7 billion compared to the net $42.8 billion for the 12-months ending March 2024. For 2024 it was up $53.4 billion, 2023 was $36.5 billion, 2022 was $68.2 billion, and in 2021 it was up $69.8 billion, with the 2020 net change negative as 43 S&P 500 issues suspended their dividends at –$40.8 billion. Increases for the 12-month March 2025 period were $68.2 billion versus the previous $68.1 billion, and decreases were $15.6 billion compared to $25.2 billion in the previous period. 

“Dividend growth typically is strongest in Q1, as most companies finish their fiscal year and prepare for their shareholder meeting. For Q1 2025, growth, while noticeably slower, did continue and was in line with expectations given the current economic uncertainties. This uncertainty however did not appear to stop increases, though it did limit them, as forward commitment levels appeared shy,” said Howard Silverblatt, Senior Index Analyst at S&P Dow Jones Indices.

Silverblatt continued: “Given the current level of uncertainty over global government policy and individuals concern over employment and inflation, companies may continue to evaluate the developing changes, which could translate into fewer forward commitments (i.e. production, capital expenditures, employment or dividends).”

Silverblatt concluded: “With the speed of the actions and potential negotiations and adjustments ahead, Q2 2025 dividend increases may be limited as companies take a wait-and-see approach. However, working with a base case for a higher-level resolution by mid-year, the second half of 2025 might be stronger than historical averages for dividends. For 2025, the S&P 500 is expected to post a record payment, posting a 6-7% increase in dividend payments, which is down from the pre-2025 8% expectation; for 2024 dividend payments increased 6.4% and in 2023 5.1%.”

S&P 500^® Dividends

On a per share basis, S&P 500 Q1 2025 dividend payments decreased 2.2% to $19.37 per share from Q4 2024’s $19.81 record and were up 7.3% from Q1 2024’s $18.06 payment. For the 12-months ending March 2025 the index paid $76.15 compared to $70.82 for the 12-month March 2024 period; for 2024 it paid $74.83 and in 2023 it paid $70.30.

Additional findings from S&P Dow Jones Indices’ quarterly analysis of U.S. dividend activity includes:

Dividend Increases (defined as either an increase or initiation in dividend payments):

• 758 dividend increases were reported during Q1 2025 compared to 796 during Q1 2024, a 4.8% year-over-year decrease.
• Total dividend increases were $19.5 billion for the quarter, down from $22.7 billion in Q1 2024.
• For the 12-months ending in March 2025, 2,412 issues increased their payments, a tick higher than the 2,411 issues for the 12-months ending in March 2024.
• Total dividend increases for the 12-month period were $68.2 billion, up from $68.1 billion in the prior 12-month period.

Dividend Decreases (defined as either a decrease or suspension in dividend payments):

• 57 issues decreased dividends in Q1 2025, an 11.8% year-over-year decrease compared to 51 issues in Q1 2024.
• Dividend decreases were $4.2 billion in Q1 2025, compared to $6.7 billion in Q1 2024.
• For the 12-months ending in March 2025, 138 issues decreased their dividend payments, a 37.0% decrease compared to the 219 decreases within the prior 12-month period.
• Dividend decreases were $15.6 billion for the current 12-month period, a 38.3% decrease from the prior 12-month period’s $25.2 billion.

Non-S&P 500 Domestic Common Issues (for issues yielding 10% or less):

• The percentage of non-S&P 500 domestic dividend-paying common issues increased to 20.3% from Q4 2024’s 20.1% and were down from Q1 2024’s 20.5%.
• The weighted indicated dividend yield for paying issues was 2.78% in Q1 2025, down from 2.83% in Q4 2024 and down from 2.86% in Q1 2024. The average indicated yield increased to 3.32% in Q1 2025 compared to Q4 2024’s 3.19% and was down from 3.28% in Q1 2024.

Large-, Mid-, and Small-Cap Dividends:

• 407 issues or 80.9% within the S&P 500 currently pay a dividend, the same as in Q4 2024 and up from the 404 which paid in Q1 2024; 28 of the 30 constituents within the Dow Jones Industrial Average^® pay a dividend with an average yield of 1.93% for all issues and 2.07% for the paying issues.
• 66.3% of S&P MidCap 400^®issues pay a dividend, up from 66.1% in Q4 2024 and up from 65.6% in Q1 2024. 57.8% of S&P SmallCap 600^®issues pay a dividend, up from 57.6% in Q4 2024 and down from 59.7% in Q1 2024.
• Yields were higher for Q1 2025 as prices declined, large-cap yields increased to 1.37% (1.28% for Q4 2024 and 1.38% for Q1 2024), mid-caps increased to 1.59% (1.46% for Q4 2024 and 1.48% for Q1 2024), and small-caps increased to 1.79% (1.62% for Q4 2024 and 1.77% for Q1 2024).
• The yields across dividend-paying market-size classifications varied with large-caps increasing to 1.64% for Q1 2025 (1.56% in Q4 2024 and 1.72% in Q1 2024), mid-caps increasing to 2.37% (2.22% in Q4 2024 and 2.18% in Q1 2024), and small-caps increasing to 3.04% (2.81% in Q4 2024 and 2.90% in Q1 2024).

For more information about S&P Dow Jones Indices, please visit https://www.spglobal.com/spdji/en/.

ABOUT S&P DOW JONES INDICES

S&P Dow Jones Indices is the largest global resource for essential index-based concepts, data and research, and home to iconic financial market indicators, such as the S&P 500® and the Dow Jones Industrial Average®. More assets are invested in products based on our indices than products based on indices from any other provider in the world. Since Charles Dow invented the first index in 1884, S&P DJI has been innovating and developing indices across the spectrum of asset classes helping to define the way investors measure and trade the markets.

S&P Dow Jones Indices is a division of S&P Global (NYSE: SPGI), which provides essential intelligence for individuals, companies, and governments to make decisions with confidence. For more information, visit https://www.spglobal.com/spdji/en/.

S&P DJI MEDIA CONTACTS:

Alyssa Augustyn
, External Communications – Americas
(+1) 773 919 4732 [email protected] 

S&P DJI INDEX SERVICES:

Howard Silverblatt
, Senior Index Analyst
(+1) 973 769 2306 [email protected] 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/sp-dow-jones-indices-reports-us-common-indicated-dividend-payments-increase-of-15-3-billion-in-q1-2025-as-dividend-growth-continues-to-slow-302422781.html

SOURCE S&P Dow Jones Indices